Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey
✍ Scribed by O. Ilhan; H. Akan; H. Koç; G. Gürman; Ö. Arslan; M. Özcan; H. Erdi; C. Erdem; N. Konuk; A. Uysal; M. Beksaç
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 132 KB
- Volume
- 39
- Category
- Article
- ISSN
- 1269-3286
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Non-melanoma skin carcinoma is more common in transplant recipients, probably because of immunosuppression. an increased risk of developing melanoma could be a late effect of transplantation. the number of naevi, which is a risk marker for melanoma, is increased in renal transplant r
We report a case of severe gastro-intestinal (G-I) graft-vs.-host disease (GVHD) successfully treated with intra-mesenteric artery steroid administration. A 29-year-old man with severe aplastic anemia (SAA) was submitted to HLA-identical unrelated allogeneic bone marrow transplantation (BMT) and was
In vitro depletion of mature pan-T lymphocytes has been widely and successfully used to prevent acute graft-versus-host disease (GVHD) after allogeneic bone-marrow transplantation (BMT). However, this procedure has been associated with a high incidence of graft failure and leukemic relapse. In this